Serojec

Serojec Overview

Serojec develops drugs to treat premature ejaculation, by combining various drugs on the market. One drug is from the tricyclic family of antidepressants, used in low dosage, which then reaches only the spinal column, not the brain. The second drug is an alkaloid that relaxes the blood vessels. The combination enables each drug to neutralize the other's side effects. The alkaloid is a known drug for the treatment of premature ejaculation. The combinations of both drugs are patented. The company has completed a Phase I trial to verify that the project is safe. A secondary purpose was to show signs of effectiveness. The trial showed that the duration of erection was extended several times over, even though all of the volunteers in the trial were functioning normally. The trial was conducted in cooperation with the University of Vienna.

Latest News

Jan 8, 2020 · en.globes.co.il

growth-positive

Serojec develops drug to treat premature ejaculation

Dr. Daniel Drai has developed a treatment for premature ejaculation using a combination of drugs. He has registered a patent for the treatment and founded a company called Serojec. The company has completed a Phase I trial to verify the safety and effectiveness of the treatment. Dr. Drai is now seeking financing or cooperation with a drug company to further develop the product. He believes that the market for premature ejaculation treatment is even larger than the market for Viagra.

InvestmentPartners

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Tel Aviv, Israel

Photos & Videos

No files yet

Serojec Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info